{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:56:29Z","timestamp":1781646989384,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP256f0137008"],"award-info":[{"award-number":["JP256f0137008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Total mesorectal excision (TME) is the standard treatment for middle to lower rectal cancer. However, it is associated with significant postoperative complications and functional impairments. Local excision (LE) combined with neoadjuvant radiotherapy (RT) has emerged as a less invasive alternative and has shown potential for organ preservation. This study aimed to compare the short-term and long-term outcomes of LE\u2009+\u2009RT versus TME in selected patients with rectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis were conducted following a comprehensive literature search of human studies published in English, completed by April 2025. Inclusion criteria consisted of rectal cancer up to cT3 disease and\/or showed a favorable response to neoadjuvant therapy. Postoperative outcomes assessed included operative time, blood loss, morbidity, length of hospital stay, and permanent stoma rate. Oncological and survival outcomes were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of six studies were included. They consisted of five randomized controlled trials and one prospective clinical trial, with a total of 679 patients. Of these, 366 were treated with LE\u2009+\u2009RT and 313 with TME. Pooled analysis showed that the LE\u2009+\u2009RT group was associated with a significantly shorter operative time, a lower overall morbidity, and a shorter postoperative hospital stay. No significant differences were observed between the groups in oncological or survival outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests that, in selected rectal cancer patients, LE\u2009+\u2009RT may represent a less invasive alternative with comparable oncological outcomes to TME. LE\u2009+\u2009RT may subsequently be a viable treatment option, especially in patients seeking organ preservation or in patients unfit for TME.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-026-04304-8","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:26:39Z","timestamp":1775114799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic review and meta-analysis comparing postoperative and oncological outcomes between local excision plus radiotherapy versus total mesorectal excision for rectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Daichi","family":"Kitaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Forgione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Innocenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Esp\u00ednola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Marescaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"4304_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W van Gijn","year":"2011","unstructured":"van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12:575\u201382.","journal-title":"Lancet Oncol"},{"key":"4304_CR2","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114\u201323.","journal-title":"N Engl J Med"},{"key":"4304_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/bjs.5679","volume":"94","author":"L P\u00e5hlman","year":"2007","unstructured":"P\u00e5hlman L, Bohe M, Cedermark B, Dahlberg M, Lindmark G, Sj\u00f6dahl R, et al. The Swedish rectal cancer registry. Br J Surg. 2007;94:1285\u201392.","journal-title":"Br J Surg"},{"key":"4304_CR4","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","volume":"23","author":"KC Peeters","year":"2005","unstructured":"Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients\u2013a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199\u2013206.","journal-title":"J Clin Oncol"},{"key":"4304_CR5","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1200\/JCO.2005.05.256","volume":"23","author":"CA Marijnen","year":"2005","unstructured":"Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2005;23:1847\u201358.","journal-title":"J Clin Oncol"},{"key":"4304_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ijrobp.2015.02.021","volume":"92","author":"A Gilbert","year":"2015","unstructured":"Gilbert A, Ziegler L, Martland M, Davidson S, Efficace F, Sebag-Montefiore D, et al. Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting. Int J Radiat Oncol Biol Phys. 2015;92:555\u201367.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4304_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3109\/0284186X.2015.1088171","volume":"55","author":"LM Wiltink","year":"2016","unstructured":"Wiltink LM, Marijnen CA, Meershoek-Klein Kranenbarg E, van de Velde CJ, Nout RA. A comprehensive longitudinal overview of health-related quality of life and symptoms after treatment for rectal cancer in the TME trial. Acta Oncol. 2016;55:502\u20138.","journal-title":"Acta Oncol"},{"key":"4304_CR8","doi-asserted-by":"crossref","unstructured":"Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr., Silva e Sousa AH Jr. et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240: 711-7; discussion 7\u20138.","DOI":"10.1097\/01.sla.0000141194.27992.32"},{"key":"4304_CR9","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S1470-2045(15)00215-6","volume":"16","author":"J Garcia-Aguilar","year":"2015","unstructured":"Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015;16:1537\u201346.","journal-title":"Lancet Oncol"},{"key":"4304_CR10","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","volume":"29","author":"M Maas","year":"2011","unstructured":"Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29:4633\u201340.","journal-title":"J Clin Oncol"},{"key":"4304_CR11","doi-asserted-by":"publisher","first-page":"e2350903","DOI":"10.1001\/jamanetworkopen.2023.50903","volume":"7","author":"HM Thompson","year":"2024","unstructured":"Thompson HM, Omer DM, Lin S, Kim JK, Yuval JB, Verheij FS, et al. Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial. JAMA Netw Open. 2024;7:e2350903.","journal-title":"JAMA Netw Open"},{"key":"4304_CR12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/DCR.0000000000000613","volume":"59","author":"S Hallam","year":"2016","unstructured":"Hallam S, Messenger DE, Thomas MG. A Systematic Review of Local Excision After Neoadjuvant Therapy for Rectal Cancer: Are ypT0 Tumors the Limit? Dis Colon Rectum. 2016;59:984\u201397.","journal-title":"Dis Colon Rectum"},{"key":"4304_CR13","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","volume":"391","author":"MJM van der Valk","year":"2018","unstructured":"van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391:2537\u201345.","journal-title":"Lancet"},{"key":"4304_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1200\/JCO.23.01208","volume":"42","author":"FS Verheij","year":"2024","unstructured":"Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT, et al. Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial. J Clin Oncol. 2024;42:500\u20136.","journal-title":"J Clin Oncol"},{"key":"4304_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/s-0035-1562889","volume":"28","author":"TJ Saclarides","year":"2015","unstructured":"Saclarides TJ. Transanal Endoscopic Microsurgery. Clin Colon Rectal Surg. 2015;28:165\u201375.","journal-title":"Clin Colon Rectal Surg"},{"key":"4304_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"4304_CR17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"4304_CR18","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"4304_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"4304_CR20","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27:1785\u2013805.","journal-title":"Stat Methods Med Res"},{"key":"4304_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00464-007-9596-y","volume":"22","author":"G Lezoche","year":"2008","unstructured":"Lezoche G, Baldarelli M, Guerrieri M, Paganini AM, De Sanctis A, Bartolacci S, et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc. 2008;22:352\u20138.","journal-title":"Surg Endosc"},{"key":"4304_CR22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/bjs.8821","volume":"99","author":"E Lezoche","year":"2012","unstructured":"Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg. 2012;99:1211\u20138.","journal-title":"Br J Surg"},{"key":"4304_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","volume":"390","author":"E Rullier","year":"2017","unstructured":"Rullier E, Rouanet P, Tuech JJ, Valverde A, Lelong B, Rivoire M, et al. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet. 2017;390:469\u201379.","journal-title":"Lancet"},{"key":"4304_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S2468-1253(20)30333-2","volume":"6","author":"SP Bach","year":"2021","unstructured":"Bach SP, Gilbert A, Brock K, Korsgen S, Geh I, Hill J, et al. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Lancet Gastroenterol Hepatol. 2021;6:92\u2013105.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4304_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.annonc.2022.09.160","volume":"34","author":"X Serra-Aracil","year":"2023","unstructured":"Serra-Aracil X, Pericay C, Badia-Closa J, Golda T, Biondo S, Hern\u00e1ndez P, et al. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study). Ann Oncol. 2023;34:78\u201390.","journal-title":"Ann Oncol"},{"key":"4304_CR26","doi-asserted-by":"publisher","first-page":"115156","DOI":"10.1016\/j.ejca.2024.115156","volume":"216","author":"X Qiu","year":"2025","unstructured":"Qiu X, Zhou J, Qiu H, Shen Z, Wu B, Jia W, et al. A new treatment strategy for mid-low rectal cancer patients exhibiting a clinical complete or near-complete response to neoadjuvant chemoradiotherapy: Transanal endoscopic microsurgery --A multicenter prospective case-control clinical trial by MONT-R. Eur J Cancer. 2025;216:115156.","journal-title":"Eur J Cancer"},{"key":"4304_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S2468-1253(19)30410-8","volume":"5","author":"E Rullier","year":"2020","unstructured":"Rullier E, Vendrely V, Asselineau J, Rouanet P, Tuech JJ, Valverde A, et al. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial. Lancet Gastroenterol Hepatol. 2020;5:465\u201374.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4304_CR28","doi-asserted-by":"crossref","unstructured":"Serra-Aracil X, Pericay C, Cidoncha A, Badia-Closa J, Golda T, Kreisler E et al. Chemoradiotherapy and Local Excision vs Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer: The TAUTEM Randomized Clinical Trial. JAMA Surg. 2025;160:783\u201393.","DOI":"10.1001\/jamasurg.2025.1398"},{"key":"4304_CR29","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","volume":"28","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv22\u201340.","journal-title":"Ann Oncol"},{"key":"4304_CR30","doi-asserted-by":"crossref","unstructured":"Hofheinz RD, Fokas E, Benhaim L, Price TJ, Arnold D, Beets-Tan R et al. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36:1007\u201324.","DOI":"10.1016\/j.annonc.2025.05.528"},{"key":"4304_CR31","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/bjs.8700","volume":"99","author":"FM Smith","year":"2012","unstructured":"Smith FM, Chang KH, Sheahan K, Hyland J, O\u2019Connell PR, Winter DC. The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy. Br J Surg. 2012;99:993\u20131001.","journal-title":"Br J Surg"},{"key":"4304_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/DCR.0b013e3182a84eba","volume":"57","author":"FM Smith","year":"2014","unstructured":"Smith FM, Wiland H, Mace A, Pai RK, Kalady MF. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2014;57:311\u20135.","journal-title":"Dis Colon Rectum"},{"key":"4304_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/bjs\/znac372","volume":"110","author":"PA Custers","year":"2022","unstructured":"Custers PA, Geubels BM, Beets GL, Lambregts DMJ, van Leerdam ME, van Triest B, et al. Defining near-complete response following (chemo)radiotherapy for rectal cancer: systematic review. Br J Surg. 2022;110:43\u20139.","journal-title":"Br J Surg"},{"key":"4304_CR34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/bjs.1800600908","volume":"60","author":"AG Parks","year":"1973","unstructured":"Parks AG, Stuart AE. The management of villous tumours of the large bowel. Br J Surg. 1973;60:688\u201395.","journal-title":"Br J Surg"},{"key":"4304_CR35","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s00464-010-0927-z","volume":"24","author":"S Atallah","year":"2010","unstructured":"Atallah S, Albert M, Larach S. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc. 2010;24:2200\u20135.","journal-title":"Surg Endosc"},{"key":"4304_CR36","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1007\/s00464-019-07259-y","volume":"34","author":"X Serra-Aracil","year":"2020","unstructured":"Serra-Aracil X, Rebasa-Cladera P, Mora-Lopez L, Pallisera-Lloveras A, Serra-Pla S, Navarro-Soto S. A scoring system to predict complex transanal endoscopic surgery. Surg Endosc. 2020;34:4828\u201336.","journal-title":"Surg Endosc"},{"key":"4304_CR37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12885-019-5581-9","volume":"19","author":"JL Lee","year":"2019","unstructured":"Lee JL, Lim SB, Yu CS, Park IJ, Yoon YS, Kim CW, et al. Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial. BMC Cancer. 2019;19:404.","journal-title":"BMC Cancer"},{"key":"4304_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12885-016-2557-x","volume":"16","author":"WA Borstlap","year":"2016","unstructured":"Borstlap WA, Tanis PJ, Koedam TW, Marijnen CA, Cunningham C, Dekker E, et al. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer. BMC Cancer. 2016;16:513.","journal-title":"BMC Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04304-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:23:18Z","timestamp":1781644998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04304-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4304"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04304-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review and meta-analysis based exclusively on previously published studies and did not involve direct human participation, identifiable personal data, or intervention by the authors. Therefore, ethics committee approval and informed consent were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}